Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
|Condition or Disease||Intervention/Treatment||Phase|
Patients enrolled on CCR clinical protocols may require long term follow-up to assess outcome (e.g., survival) or the effects of prior therapy.
Keeping the primary treatment protocols open after accrual is complete in order to follow patients for long term outcome is an administrative burden on investigators and the IRB.
-To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol.
-Patients who were previously enrolled on a CCR protocol and who are not eligible for an active NCI intramural primary research protocol.
The medical procedures/tests will be based on the patient's diagnosis, treatment and supporting clinical information. This is a follow-up study in which only standard tests and procedures are to be performed.
Clinical information that is relevant to the patients prior protocols will be collected for research purposes.
Procedures that entail more than minimal risk to the patient should not be performed for research purposes on this protocol.
Arms and Interventions
Patients who were previously enrolled on a CCR protocol and need follow-up by CCR Investigators.
Primary Outcome Measures
- To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol [30 years]
Provision of a mechanism to follow selected CCR patients when their protocols have been terminated.
- ELIGIBILITY CRITERIA:
Patients of any age who were previously enrolled on a CCR protocol.
Not eligible for or unwilling to participate in an active NCI intramural primary research protocol.
CCR investigator decides it is in the best interests of the patient and the CC for the patient to be seen in follow-up visits at the NIH.
Patient or Legally Authorized Representative (LAR)/guardian is able to provide informed consent.
Contacts and Locations
|1||National Institutes of Health Clinical Center, 9000 Rockville Pike||Bethesda||Maryland||United States||20892|
Sponsors and Collaborators
- National Cancer Institute (NCI)
- Principal Investigator: James L Gulley, M.D., National Cancer Institute (NCI)
Study Documents (Full-Text)None provided.